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With rising costs and increasing complexities, many hospitals seek to better 
understand the intricate details of their operations.  Increasingly, these organizations have 
a strong desire to accurately predict the resources required to effectively treat their patient 
load.  This research investigates patient length-of-stay in a hospital neurological unit 
using an empirical modeling approach.  Factors significantly affecting patient length of 
stay were identified and used to construct a regression model.  The predictive model 
provides hospital decision makers with a compact tool to input what-if scenarios and 
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ANALYSIS OF PATIENT INFORMATION:          
 
AN EMPIRICAL MODELING APPROACH 
   
 





 Currently, there is a growing need and interest to improve the quality and 
efficiency of health care, which emphasizes the necessity of good indicators to determine 
this.  Furthermore, hospitals and other health care facilities are experiencing difficulties 
providing reliable care while maintaining sizable profits.  As a result, many are looking at 
innovative ways to better utilize the often limited resources they have.  Several have 
determined the best way to accomplish this is to better understand and ultimately exercise 
better control over their operations.  Because it is often related to total costs, managing 
patient length-of-stay (LOS) has become the main focus in health care settings and many 
hospitals have turned to LOS prediction models to improve their resource utilization 
[Blais 2003, Omachonu 2004]. 
 Hospitals have a strong desire to be able to accurately predict LOS and, more 
specifically, costs by using the often limited information from incoming patients.  LOS is 
becoming an increasingly important and primary performance indicator for hospitals and 
other health care facilities and has often been used as an indicator of inpatient care 
efficiency [Blais 2003].  Due to its clear meaning as one of the main sources of hospital 
costs and because it can also be used as an indicator of quality patient care, it is often 
viewed as a measure of effective treatment and as a means for managing cost.  Because 
of this, hospital administrators generally focus on LOS as an indicator of the quality of 
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care and as an important variable in determining budgets based on access (i.e., 
admissions to the unit per year).  As a result, many hospitals have dedicated countless 
efforts and resources to better understand what ultimately determines LOS [Omachonu 
2004].   
Ideally, these facilities would wish to rely on predetermined expected LOS 
values, which are calculated based on statistical patient data from the previous fiscal year 
[Centers for Medicare and Medicaid Services 2002].  However, this approach does not 
consider how these expected values may be impacted by certain patient characteristics or 
other factors.  In most cases, a younger, healthier patient with little or no medical history 
is going to have a shorter LOS than a frailer, elderly one who has had prior related 
diagnoses.  However, the current system makes no adjustment in these instances.  
Consequently, these expected LOS values tend to have excessive variability which 
obviously makes them highly unreliable.   
An alternative is to model the current hospital operation, or system, to more 
accurately predict an incoming patient’s LOS.  These prediction models generally use 
historical patient data to determine the predominant factors and indicators that drive LOS 
and costs.  While patient characteristics are the obvious predictors to use, clinical aspects 
such as physician experience and hospital policies have also been used.   
Multiple regression analysis is typically used to build these models.  After 
validation testing, these models can be analyzed using simulation software, which will 
derive statistical operating characteristics, such as mean LOS and patient load, of the 
entire hospital system as a whole.  Ultimately, hospital administrators will have a model 
that not only characterizes their entire operation, but also has the capability to analyze 
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various what-if scenarios affecting resource utilization. 
 
1.2 Problem Objective 
 Using neurological patient data provided by a local hospital, a prediction model 
will be created to determine patient LOS and an indirect associated cost of treatment.  
Using this model, a hospital could match their performance compared to the government 
standard and consider dropping more costly treatments in exchange for more profitable 
ones.  They could also allocate and schedule resources, such as beds and staff, 
accordingly.  Other items the model may be used to determine:   
• Are there certain patient profiles that are prone to have longer/shorter stays 
compared to the expected LOS?   
• What, if any, insurance providers encourage a shorter stay compared to other 
providers?   
• Are there certain profiles the hospital should target to reduce LOS and/or increase 
profit? 
 
1.3 Method of Approach 
1.3.1 Problem Background 
Good Samaritan Hospital of Dayton, OH, is one of the leading health care 
facilities in southwestern Ohio. It is currently performing a major renovation to its 
facilities with its neurology department being expanded as a result of this.  With this 
upgrade, the hospital will become a leading certified stroke care unit in the area and is 
expected to see a dramatic increase in not only stroke patients, but neurosurgical and 
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neuromedical cases as well.  Also, another neurosurgeon is expected to be hired in the 
near future, further increasing the influx of patients.  Because of these changes, the 
hospital feels it needs a better understanding of its operations.  They also desire to know 
the consequences of varying resource allocations, such as beds and staffing.       
 
1.3.2 Overview of Neurology and Neurological Disorders  
 Neurology is the branch of medicine that deals with the central nervous system 
and its disorders. Neurological disorders are those affecting the central nervous system 
(brain, brainstem, cerebellum), the peripheral nervous system (peripheral nerves - cranial 
nerves), or the autonomic nervous system (parts of which are contained in both of the 
former).  While stroke is the most common neurological ailment, other disorders include 
migraine headaches, epileptic seizures, and cerebral palsy [National Institutes of Health 
2006]. 
 Stroke is defined as rapidly developed clinical signs of focal (or global) 
disturbance of cerebral function, lasting more than 24 hours or leading to death.  Though 
its cause has yet to be determined, it is usually due to a blockage of an artery in the brain, 
called a cerebral infraction.  In minor instances, stroke results from a cerebral 
hemorrhage, or rupture of a blood vessel in the brain.  More information on neurology 
and all neurological disorders can be found at the website of the National Institute of 





1.3.3 Patient Classification (Diagnostic Related Groups) 
 
 Hospitals classify medical patients into clinically cohesive groups, called 
Diagnostic Related Groups (DRGs), which typically consume the same amount and type 
of hospital resources.  The DRG system was implemented in 1983 when Congress 
mandated a national hospital prospective payment system (PPS) for all Medicare patients.  
The PPS utilizes DRGs to determine hospital reimbursement.  The Centers for Medicare 
and Medicaid Services (CMS) administers the PPS and issues all rules and changes with 
regard to DRGs.  Although the DRG system was originally intended exclusively for 
Medicare patients, many hospitals now use it as a means to charge all their patients.  
However, the actual payment of non-Medicare patients varies according to their 
individual insurance providers [Centers for Medicare and Medicaid Services 2002].      
The DRG system is used to predict costs of treatment and length of stay. It is a 
tool that reflects the severity of the diagnosed ailment and difficulty of treatment and is 
expected to indicate an efficient payment mechanism for health care.  A basic assumption 
is that a patient in the same DRG will require similar resources regardless of the type or 
location of the hospital.  Relative weights (RW) are assigned to each DRG to indicate the 
expected resource consumption, based on historical data, required to treat a certain 
ailment.  A high RW indicates the case requires a high level of hospital resources, and in 
most cases, a longer LOS.  Base rate is the amount of money paid to the hospital per unit 
of RW.  The formula for computing the total hospital payment for each DRG is then: 
 
       DRG Relative Weight x Hospital Base Rate = Payment to Hospital      (1-1)  
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For example, in 2005 the RW for a stroke was 1.2719 and the hospital base rate 
was $4500, which results in a payment of $5,723.55 (1.2719 * $4500). Each DRG also 
has an expected LOS value, which is partially used to determine the RW.  In other words, 
the longer the LOS, the higher the charge will generally be.  As stated earlier, the 
drawback of the RW and expected LOS values is that they give no indication of how they 
may be impacted by certain patient characteristics or other factors.  If a hospital knew 
certain scenarios that dramatically affected LOS, they potentially could plan accordingly 
to take advantage of these situations.  For example, a patient profile prone to have a much 
longer LOS than the expected value would most likely be avoided, if possible.  
Moreover, if certain diagnoses consistently result in a longer than expected LOS, the 
hospital may consider discontinuing these particular treatments [Centers for Medicare 
and Medicaid Services 2002]. 
 
1.3.4 Approach  
The model will be implemented using a variety of multivariate linear regression 
analysis techniques.  Since there is a considerable amount of data, software will be used 
extensively to accurately and efficiently handle the storage, sorting, and analysis of the 
data.  All 2k possible regressions will be studied, where k is the number of possible 
regressors, along with all the various interactions between them.  Any categorical data 
will be quantified either arbitrarily or based on some type of ranking method.   
Ultimately, all statistically significant predictor variables will be determined to 
develop a final regression model.  With this representation, a simulation model describing 
the neurological unit will be implemented.  Simulation software will be used to validate 
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and verify the regression model before performing full-scale testing and sensitivity 
analysis with it.   
 
1.4 Thesis Outline 
 This thesis consists of five chapters.  Chapter 2 reviews related research in 
predicting and modeling LOS that is relevant to this study.  Chapter 3 explains the 
methodology used in the development and testing of the regression and simulation 
models.  Chapter 4 presents the results of the analysis.  Chapter 5 presents insight and 


































There has been broad and extensive research performed in determining what 
variables impact, and to what extent, patient LOS.  Not only have various methods of 
regression analysis been used in these studies, there has also been a plethora of possible 
predictor variables studied.  In fact, it was determined that no less than 22 different 
variables influenced LOS in various studies.  While objective and quantitative indicators 
such as diagnosis and age were predominantly used, more subjective and qualitative 
types, such as patient severity, physician characteristics, and the patient's opinion of his 
or her overall health, were also commonly studied. 
The objective of this review is not only to present relevant work related to this 
research, but also to study and understand the methods and techniques previously used 
for predicting LOS in order to possibly relate it to this analysis.  While the primary focus 
of this review is on work pertaining specifically with LOS, those dealing with predicting 
patient costs are also examined.  This was done primarily because the nature of most 
hospital billing policies tends to relate health care operating costs to LOS. 
The remainder of this chapter examines relevant research in analyzing and 
predicting LOS relating to neurological cases (Section 2.2), followed by a review of other 
research relevant to predicting LOS (Section 2.3) and an overview of some of the data 
analysis methods and techniques used in these studies (Section 2.4).  The chapter 




2.2 Related Work in Predicting LOS for Neurological Cases   
 
Much of the work done in modeling LOS in neurological units has focused on 
stroke cases as they are the most common neurological ailment and typically require the 
most resources.  Strokes are the third leading cause of death in the US among people 
aged 65 and older and are also a major cause of long-term disability and rehabilitation. Its 
cost to Medicare alone has been estimated to be as high as $18 billion per year [Monane 
1996].     
Many researchers [Bohannon et. al. 2002, Evers et. al. 2002, Hakim and Bakheit 
1998 Herman et. al. 1984, Lee et al. 1997, Monane et. al. 1996, Wade and Langton 1985] 
have examined patient demographics, such as age, race, gender, and marital status, in an 
effort to determine if any are potential predictors of LOS in neurological cases.  Several 
others [Brousseau et. al. 1996, Evers et. al. 2002, Hakim and Bakheit 1998, Herman et. 
al. 1984, Monane et. al. 1996, Parsons et. al. 2003, Wade and Langton 1985] have looked 
at other indicators, such as insurance status, history of hospitalization, physician 
experience and additional diagnoses and complications the patient may or may not have 
had.   
A study performed at University Hospital Maastricht in the Netherlands dealt with 
731 stroke patients over the period of 1996-1998.  The hospital had recently implemented 
a DRG classification system similar to the US version and wanted to determine whether it 
provided an accurate prediction of the variance of costs in stroke patients.  The results 
showed that DRGs accounted for 34% of the cost variance.  Adding other variables, such 
as age, gender, and additional diagnoses the patient had, increased R2 to over 61% [Evers 
et. al. 2002]   
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 Another study [Monane et. al. 1996] looked at insurance data from 745 elderly 
stroke patients and divided them into three categories: Medicare, HMOs, and other 
(including Medicaid and private providers).  It concluded that those belonging to HMOs 
tended to have a shorter LOS, although there was evidence that many of these patients 
may have been discharged to a rehabilitation unit sooner and more often than patients 
belonging to other insurance providers.  Two other studies analyzed the relationship 
between insurance type and hospital utilization.  One study [Lagoe and Lauko 1995] 
found no significant relationship, while the other [Lanska 1994] found that LOS is indeed 
related to insurance type, primarily those patients that belong to Medicare or a HMO. 
 The majority of studies have investigated the relationships between age and 
hospital costs, but the results have been at best, contradictory.  One study [Brousseau et. 
al. 1996] reported that elderly patients require higher costs, concluding that the recovery 
of older stroke patients is longer, while other studies [Lee et. al. 1997, Wade and Langton 
1985] determined that younger patients utilized hospital services more.  Lee explained 
this by proposing that older patients receive a less aggressive approach to treatment and 
tend to expire at a higher rate and earlier in the treatment phase.  He also presented 
evidence that some hospitals ‘pad’ their LOS statistics by discharging their terminally ill 
patients to Hospices and other similar facilities. 
 While four studies [Burns and Douglas 1991, Hakim and Bakheit 1998, Monane 
et. al. 1996, Wade and Langton 1985] examined gender relationships, only one found a 
significant difference between men and women.  Burns determined that men of all ages 
generally have a longer LOS.  Out of four studies that investigated marital status 
[Christina et. al. 1991, Herman et. al. 1984, Monane et. al. 1996, Wade and Langton 
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1985], two [Monane et. al. 1996, Wade and Langton 1985] concluded that being single 
led to a longer hospital stay.  Several authors [Burns and Douglas 1991, Christina et. al. 
1991, Hakim and Bakheit 1984, Wade and Langton 1985] examined physician 
characteristics and found that the more experienced doctors [Burns and Douglas 1991] 
and those with a more general background [Christina et. al. 1991] tended to keep their 
patients in the hospital longer.  Hakim also concluded that LOS was generally shorter in 
smaller hospitals within metropolitan areas and also in hospitals with a high nurse to bed 
ratio.     
There have also been several scales developed to better, albeit subjectively, 
describe a patient’s condition or functional level.  The Rankin scale, developed by a 
group of neurologists, estimates a patient’s level of functioning before the stroke from 0 
‘no symptoms’ to 5 ‘severe handicap’.  The Canadian Neurological Scale ranges from 1.5 
‘severely handicapped’ to 10 ‘no symptoms’.  [Evers et. al. 2002] found that men who 
score more severely on the Rankin scale induce significantly higher costs than do women 
with the same scale level.     
 Other studies also attempted to quantify patient severity levels. In his research, 
Bohannon [2002] utilized two scales: the National Institutes of Health Stroke Scale and 
Barthel ADL (Activity of Daily Living) Index score.  The Barthel Index consists of two 
parts, pre-stroke and post-admission, and is used to gauge how well the patient 
independently performs 10 activities (e.g. dressing, walking).  Bohannon used these two 
indexes, along with age and gender, to predict LOS, total patient charges, and discharge 
destination.  Analysis showed that once the post-admission Barthel score was obtained, 
no other variable contributed to LOS prediction.  Wade and Langton [1985] also utilized 
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the Barthel Index but found very little relevance while using it. 
 
2.3 Related Work in Predicting LOS in Non-Neurological Cases 
 Additional studies non-related to neurology were also analyzed.  It was believed 
further insight into predicting LOS could be gained from these while at the same time 
avoiding ‘tunnel-vision’ from focusing too strictly on stroke cases.  This section centers 
more on the techniques used to gain enhanced insight into patient characteristics and 
modeling of the treatment process itself.    
A study [Omachonu et. al. 2004] of about 1500 Medicare patients at the 
University of Miami Medical Center investigated patient characteristics and clinical 
indicators for their top 5 DRGs (1, 127, 430, 462, 489) according to patient volume.  
They determined that approximately 60% of LOS variance is explained by patient 
characteristics and diagnosis.  For DRG 1(Craniotomy, age > 17, except for trauma), 
patients admitted through the emergency room tended to have a longer LOS than non-
emergency patients, while married patients have a shorter LOS than unmarried patients.  
For DRG 127 (Heart failure and shock), results indicate that being male, American 
Indian, Cuban, Hispanic, or Caucasian would have an increased LOS of 0.72, 0.48, 0.54, 
0.97, and 0.57 days, respectively.  For DRG 430 (Psychoses), older, white male patients, 
who at some point during their stay were transferred within the hospital, will generally 
stay longer.  
Another study [Parsons et. al. 2002] that tested patients with respiratory problems 
developed a pre-admittance questionnaire consisting of 30 items.  The answers were used 
to generate values for five patient functional scales: physical, role, emotional, social, and 
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cognitive.  These were then used to derive a global QL (Quality of Life) score.  They also 
measured the patient’s 6-minute walking distance (6MWD) and administered other 
physical tests that measured lung capacity and function.  The results showed that for 
patients experiencing fewer complications, QL and 6MWD were the strongest predictors 
of LOS.   
Still another study [Weingarten et. al. 1997] evaluated the relationship between 
socioeconomic status and hospital resource utilization as measured by LOS for elderly 
Medicare patients, age 65 and older, within Shelby County, Tennessee.  Variations in 
length of stay were compared across income groupings for seven different Diagnosis 
Related Groups (DRGs) and relative effects are measured for socioeconomic status, age, 
race, gender, discharge status, and severity of illness.  Despite the lack of provider 
specific and patient specific information, the analysis does suggest that, once patients 
access the medical care system, socioeconomic status has a limited effect on discharge 
decisions. The results also indicate that the effect of administratively necessary days on 
LOS needs further policy review. 
In a large university hospital in Canada, one study [Keefler et. al. 2001] was done 
to examine the effects of psychosocial problems on LOS, controlling for patient 
demographics and medical condition.  Mean LOS for DRGs were used as a response for 
severity of medical condition, and a subjective classification system called Person-in-
Environment (PIE) was used to measure psychosocial problems. Data were collected on a 
sample of 160 patients: 78 in psychiatry and 82 in medical/surgical wards. In a regression 
analysis, the severity of the patient's psychosocial problem was a more significant 
predictor of LOS than the DRG variable. The identification of psychosocial problems and 
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their severity add an important dimension to research into the effectiveness of social 
workers in reducing length of stay. Health providers found patients having significantly 
more problems related to their social role functioning tended to have a longer LOS than 
patients with problems in the hospital environment. 
 
2.4 Data Analysis Methods and Techniques 
  Since most researchers tend to work with large quantities, many choose to use a 
top-to-bottom approach in analyzing their data.  Once they determine exactly what 
indicators they were going to study and the techniques they are to use, they analyze the 
data using advanced software packages. 
    Some of the common software used was SAS (Statistical Analysis System) 
(Ver 6.12) [Monane et. al. 1996, Omachonu et. al. 2004], of SAS Institute Inc in Cary, 
NC, Statview II (Ver 1.03) [Inouye 2001], a statistical program developed by Abacus 
Concept in Berkeley, CA, and SPSS (Statistical Package for the Social Sciences) (Ver 
10.0) [Bohannon et. al. 2002, Brousseau et. al. 1996, McKenna et. al. 2002] software, 
created by SPSS Inc. of Chicago, IL.  
 For simplicity, data was often grouped into bins, although the approaches vary 
considerably.  For example, Omachonu et. al. [2004] divided their age data into 5-year 
increments while McKenna et. al. [2002] and Monane et. al. [1996] had only two age 
groups (<75 and >=75).  Furthermore, while most chose to make LOS continuous, 




2.5 Overview of Software Applications 
2.5.1 MATLAB (Matrix Laboratory) 
 MATLAB v7.1 is a high-level programming language that uses matrix-based 
calculations and techniques to solve complex numerical problems.  It utilizes high-quality 
graphics and also provides a convenient interface to built-in state-of-the-art subroutine 
libraries.  It also has an interactive interface, reliable algorithmic foundation, and a fully 
extensible computing environment.  For more information concerning MATLAB 
software, go to: http://www.mathworks.com/products/matlab/ 
 
2.5.2 ARENA 
 ARENA is a high-level graphical simulation language that uses hierarchical 
models to simulate complex real-world systems.  Results are used to better understand the 
process(es) and to assist in making more informed and educated decisions relating to its 





















 Using neurological patient data provided by Good Samaritan Hospital (GSH), an 
empirical model was developed using advanced linear regression analysis techniques.  
The data includes the following information for each patient: Relative Weight (RW), 
Geometric Mean Length-Of-Stay (GMLOS), and Arithmetic Mean Length-Of-Stay 
(AMLOS), age, gender, and Insurance Provider (IP).  Details for each of these indicators 
is presented in the following section.  The objective was to determine which, if any, of 
these patient indicators significantly impact LOS.  This model was then compared to the 
output from a simulation model of the neurology unit along with general statistical 
information from the raw patient data, i.e. minimum/mean/maximum LOS, 
minimum/mean/maximum patient level.   GSH could ultimately use this regression model 
to determine a reasonably accurate expected LOS for an incoming patient based on his or 
her personal data.   Administrators will also be able to analyze various what-if scenarios 
relating to the operation of the neurology unit which will ultimately lead to better 
informed decisions concerning resources such as beds and staffing.   
 
3.2 Background of Patient Information 
 
 The patient data was provided by GSH’s finance office and consisted of 7319 in-
residence patients treated for neurological symptoms from January 2002 to June 2005.   
The contents of the patient data are discussed in the following subsections. 
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3.2.1 Patient Age and Gender 
 The patient age is given in years and has a mean of 64.35, a standard deviation of 
18.03, and a minimum and maximum of 14 and 105, respectively.  There are 4174 
(57.03%) females and 3145 (42.97%) males.  
 
3.2.2 Patient Diagnosis and corresponding Relative Weight, GMLOS, and AMLOS 
 Shortly after being admitted, each patient is given a principal diagnosis code, 
based on his or her ailment(s).  This code, along with other related codes, is assigned to 
one and only one DRG.  As stated earlier in Chapter 1, each DRG has associated RW and 
LOS values.  These LOS values consist of AMLOS, which is generally used as an 
expected LOS based on similar historical cases requiring the same type of treatment, and 
GMLOS, which is indirectly used to determine the actual payment.  On average, AMLOS 
is 30% higher than GMLOS.  Because RW, AMLOS, and GMLOS are updated at the 
beginning of every fiscal year, the model will have to be updated annually to reflect these 
changes.  Note that there are 323 RWs, even though there are only 115 associated DRGs 
in this study.  This is because RWs for most DRGs vary annually due largely to inflation 
and varying treatment costs.  The changes are usually minimal and therefore should have 
little or no effect on the development and implementation of this model, at least for the 
near future.  Eventually though, these increasing RW values may result in the model 





3.2.3 Patient Insurance Provider (IP) 
 This data consists of 20 categories indicating the source of payment for all 
treatments.  In the overwhelming majority of cases, this will be some health insurance 
provider, although in a few cases, the patient pays for treatment directly (‘Self’ category).  
Patient levels for each of the 20 categories vary from 19 (Other Governmental Insurance) 
to 4958 (Medicare).  Although the DRG system was originally created exclusively for 
Medicare patients only, most hospitals, including GSH, use it for billing non-Medicare 
patients as well.  However, while all IPs are billed the same, the actual payment varies 
for each particular IP and is subject to privacy restrictions.  Therefore, this analysis can 
only determine which, if any, IPs affect LOS, but cannot explain the particular reasons 
for these irregularities.  For instance, the fact that provider A pays a higher amount than 
provider B may induce a shorter or longer stay on patient A compared to patient B, 
assuming the two patients and their diagnoses are similar.  Also, each individual IP may 
have several different coverage policies available, each with varying payment policies. 
 
3.2.4 Patient Admit and Discharge times 
 Admit and discharge times are precise to the minute and assumed, in most cases, 
to be accurate and reflect the actual time the patient was present for treatment.  
 
3.3 Exploratory Data Analysis 
 
 Since there is such a large amount of data, in some instances the model was not 
developed according to each observation of patient data.  Instead, mean LOS based on 
certain patient characteristics was used.  For example, if the regressor is RW, all the 
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patients are grouped together based on his or her particular RW.  The mean actual LOS 
values for each RW then become the “new” observations.   
 This technique was primarily used in early model development, particularly to 
find the relationships between the individual regressors and the response, actual LOS.  
However, as the model progressed, it was determined that the model could lose some of 
its information, particularly model fidelity, using this approach and eventually each of the 
patients was treated as a single observation.   
 Again, since there is an excessive amount of patient data, efficient and effective 
techniques were developed to handle it effectively.  Microsoft ExcelTM software was used 
to store and sort the data, while MATLABTM software was used to calculate statistical 
information such as computing the means, variances, and develop all regression model 
information (analysis-of-variance (ANOVA) tables, model coefficients, and residual 
terms).  For example, if GMLOS and patient age were the two regressors, Excel was used 
to sort patients, first by GMLOS, and secondly by age.  An example of this is: 























































where the first matrix is the original, unsorted data and the second is the resulting sorted 
data.  Along with the corresponding actual LOS, this sorted data would then be placed in 
a text file representing an n x 3 matrix, where n is the number of observations (patients) 
and the three columns are  represented by x1, x2, and y, respectively.  MATLAB functions 
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were then written to read in these text files and calculate statistical results for each 
combination of GMLOS and age.  Both software packages were also used to plot the 
various associated graphs.  
 
3.4 Simple Regression Analysis 
 
 Initially, each of the six regressors (RW, GMLOS, AMLOS, age, gender, and IP) 
was studied individually to determine what, if any, significance each of them had on 
LOS.  It was established in Chapter 1 that RW and expected LOS (GMLOS, AMLOS) all 
have an intuitive relationship to LOS, i.e., generally the higher these values are, the 
longer LOS and higher total costs will be, and vice versa.  Because of this, these 
regressors, which from this point on will be referred to as the DRG-regressors, were 
plotted directly against LOS.  However, using similar reasoning, there is no 
corresponding relationship between the non-DRG regressors (age, gender, IP) and LOS.  
Therefore, for these particular regressors, the response used was average percent 
difference between expected LOS (GMLOS) and actual LOS to determine how particular 









 As seen in Figures 3.1, 3.2, and 3.3 below, there is indeed an increasing 
relationship in LOS vs. RW, LOS vs. GMLOS, and LOS vs. AMLOS, respectively.  


















Figure 3.1 Mean LOS vs. Relative Weight 


















Figure 3.2 Mean LOS vs. GMLOS 
 


















Figure 3.3 Mean LOS vs. AMLOS 
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Figure 3.4 below shows a logarithmic relationship between age and LOS.   






















Figure 3.4 Mean % Difference between GMLOS and Actual LOS vs. Age 
Note that the ages were grouped into 5-year increments (11-15, 16-20,…, 101-105) and 
are plotted at the midpoint of each group (13, 18,…, 103).  It may be expected that a 
younger, healthier person will have a shorter LOS, but the “leveling off” at higher ages is 
not as easily explained.  It could actually indicate elderly patients tend to expire more 
frequently.  This could perhaps be due to their receiving less aggressive treatment due to 
frail health or a living will that has a “do not resuscitate” provision.  Figure 3.5 below 
shows that various IPs can also impact LOS.   



































































































































Figure 3.5 Mean % Difference between GMLOS and Actual LOS vs. IP 
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Again, not knowing the detail and policies of each provider, it is not possible to explain 
these trends, only that a relationship does indeed exist.   
 To examine the total variability of the data, a technique similar to the one used to 
calculate the means was used.  Figures 3.6, 3.7, and 3.8 below show how LOS variability 
increases significantly as RW, GMLOS, and AMLOS increase, respectively.   





















Figure 3.6 LOS Variance vs. Relative Weight 
 




















Figure 3.7 LOS Variance vs. GMLOS 
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Figure 3.8 LOS Variance vs. AMLOS 
   
Variability effects of the three non-DRG regressors are not nearly as significant. 
As shown in Figure 3.9 below, there is clearly no relationship between age and LOS 
variance.  



















Figure 3.9 LOS Variance vs. Age 
Using the previously defined ordering scheme for IP (Figure 3.5), Figure 3.10 reflects 
that there is also no relationship between IP and LOS variance.  
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Figure 3.10 LOS Variance vs. Insurance Provider 
Gender would prove to be more difficult to study.  This is because even though males 
have a slightly higher variance (25.60) than females (17.79), having only two levels 
makes the results inconclusive.  As a result, gender was combined with age by analyzing 
LOS variance at each age/gender combination.  Figure 3.11 below shows no noticeable 
relationship between LOS variance and age and gender. 




















Figure 3.11 LOS Variance vs. Age and Gender  
In general, the non-DRG regressors have constant variability while the DRG 
regressors do not.  This is apparent even though there is a considerable degree of 
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“unknown” variance throughout each range due to instances of only one observation at 
several values of RW, GMLOS, and AMLOS.  The interactions between the DRG and 
non-DRG regressors may show other effects, but at this point it is not necessary to study 
and analyze them.   
There are several approaches to account for this nonconstant variance.  One of 
them used in general practice is weighted least squares (WLS).  Three various methods 
using WLS are developed and implemented and will be discussed next few sections.  
 
3.5 Least Squares Approaches 
 
 General assumptions usually made regarding the linear regression model  
y = Xβ + ε are that E(ε) = 0 and Var(ε) = σ2I.  This is commonly referred to as ordinary 
least squares (OLS) and assumes the error term has mean vector 0, the variance-
covariance matrix σ2I has uncorrelated and constant errors, and the least squares criterion 
is simply the squares of the error, or residual, terms: 







ii yyS                                               (3-1) 
However, data typically possesses nonconstant error variance, making these earlier 
assumptions not only impractical, but also infeasible.  The error terms still have an 
expected value of 0, but now Var(ε) = V, where V is the variance-covariance matrix.  If 
V is strictly diagonal but with unequal diagonal elements, the observations y are 
uncorrelated with unequal variances; if some of the off-diagonal elements are nonzero, 
then the observations y are correlated.  Since neurological diseases are generally not 
communicable in anyway, it is assumed all observations are uncorrelated, and therefore V 
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is strictly diagonal.  These diagonal elements represent the estimated weight of each 
corresponding observation.  The resulting least-squares criterion now becomes: 







iii yywS                (3-2) 
The following sections describe three various methods of developing these weights. 
[Montgomery 2001].  
 
3.5.1 Modeled Variance 
In this approach, V is the variance-covariance matrix of ε, or Var(ε).  However, as 
mentioned previously in this chapter, there is a considerable degree of unknown variance 
due to instances of only one observation at several values of RW, GMLOS, and AMLOS.  
Therefore, a linear model of the variance will be developed using the estimated variances.  
A potential drawback of this model is that it could generate negative values for the 
expected variance unless nonnegativity constraints are induced on the fitted values.   
 
3.5.2 Estimating Weights via Observation Frequency 
 The premise behind this approach is to place more emphasis on observations that 
occur more frequently.  For example, if a certain category of stroke occurs 50 times more 
often than another, more weight is placed on the former because the variance estimate is 
much more accurate and reliable compared to the latter.  This method has several 
advantages.  It is an intuitive approach, relatively simple to implement, and can easily be 
updated as more patient data becomes available.  These weights are represented by W, an 
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3.5.3 Isotonic Regression 
 
 Monotonic regression is a nonparametric regression method designed for cases 
where the expected value of a response variable changes isotonically (non-decreasing) or 
antitonically (non-increasing) in relation to one or more regressor variables.  Isotonic 






)( subject to x1 ≤ x2 ≤ ··· ≤ xn , where Ci (xi) 
is a convex function of xi for each i ∈ N = {1,2, ..., n}.  The process effectively 
“smoothes out” a response, resulting in a piecewise continuous step function which will 
reduce X to k ≤ n level sets [25]. 
 Essentially, this technique will use information from non-zero adjacent variances 
to calculate a more accurate estimated variance at these points of unknown variances.  
Since the variability has been shown to be non-decreasing with RW, GMLOS and 
AMLOS, isotonic regression can be used to “fill in” the unknown variances for RW, 
GMLOS, and AMLOS with only one observation.  Figure 3.12 below gives an example 
of isotonic regression by showing the previous LOS Variance vs. RW graph (Figure 3.6) 
with its corresponding isotonic regression plot.   
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Figure 3.12 Isotonic Regression Model of LOS Variance vs. Relative Weight 
 
The plot demonstrates how the original variance values are used to form a step function 
to effectively model points where the estimated variance is zero, or unknown. 
 
3.5.4 Derivation of WLS model parameters and ANOVA terms 
Nonconstant variance dramatically alters the derivation of the model.  Before 
developing the updated model parameters and sum of square terms, a review of the 
ordinary least squares is given.  Recall that to minimize the sum of the squared error 
terms,  


















                 XβXβyXβyy TTTTT +−= 2                           (3-3) 
by satisfying: 
 










which, after solving the normal equations for β, yields: 
 
             yXXXβ TT 1)( −=     (3-5) 
 
The formulas for SSR and SSRes are also modified to accommodate the V-1 matrix 
[19].  From basic regression analysis, the total sum of squares (SST) is a measure of the 








2)(       (3-6)  
 
SST is actually the sum of two terms: regression sum of squares (SSR) and 
residual sum of squares (SSRes).  The former is generally used to indicate the proportion 
(SSR/SST) of variability that can be explained by the regression model, while the latter 
represents the unexplained variability.  They are defined as: 







    (3-7)     
  








Res )ˆ(     (3-8) 
However, in the weighted least squares case, the estimator and sum of square formulas  
are modified to accommodate the V (and W) matrix: 
 
        yVXXVXβ 11 −−−= TT 1)(     (3-9) 
 
               ))(())(( 1111111 y1yVXXVXXVy1yVXXVXX −−= −−−−−−− TTTTTRSS  (3-10) 
 
             yVXXVXXVyyVy 11111Res )(
−−−−− −= TTTTSS   (3-11) 
   
(Full derivations of these are presented in Appendix B) 
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3.6 Model Development 
3.6.1 Regression Model Development 
 
 The main focus in the development of the model is a method for dealing with the 
nonconstant (and unknown) variances.  It is imperative that these variances be accurately 
estimated and accounted for in the model.  Weighted least squares regression is an 
effective and proven method to accomplish this due to its robustness and adaptability.  
Furthermore, there are several approaches to estimating the “weights”.   
 Ultimately, four methods were studied: 
 1)  Ordinary Least Squares Method (OLS) 
This is a general un-weighted regression method and was used as the 
baseline model for comparison to the subsequent weighted methods. 
 2)  Modeled Variance Method (WLS 1) 
This is the first of the proposed weighted least squares methods.  LOS 
variance is modeled with the inverse fitted values of the resulting model 
being used as the weight estimates. 
 3) Observed Frequency Method (WLS 2)  
The concept behind this method is that the more common occurring 
observations should be weighted more than those that occur less 
frequently.  This is because there is a higher confidence in the variance 
estimate at these higher frequencies.  Therefore, the weight estimates are 
the frequencies of each corresponding observation. 
 4) Isotonic Regression Method (WLS 3) 
Because empirical evidence suggests that LOS variance is a non-
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decreasing function of RW, GMLOS, and AMLOS, as evidenced in 
Figures 3.6, 3.7, and 3.8, isotonic regression can be used to derive the 
weight estimates, which are simply the inverse values of the resulting 
isotonic regression of the estimated LOS variance.   
  
3.6.2 Simulation Model Development 
 
 Using the original patient data, a simulation model of the neurology unit was 
developed.  This was done simply by using the admit and discharge times to develop 
inter-arrival and service (treatment) times.  This model will be used for comparison with 
the eventual regression model(s). 
 
3.7 Multiple Regression Analysis 
 
Now that varying relationships between each of the regressors and LOS have been 
established, multiple regressors and their interactions can be added to the model.  Before 
accomplishing this however, several issues must be resolved, such as data representation, 
coding of the qualitative IP regressor, calculation of the variance weights, and possible 
multicollinearity effects due to high correlation between some of the regressors. 
 
3.7.1 Variable Scaling 
  A uniform scaling system for the regressors was implemented.  This was done 
because it would be very difficult to establish and analyze interactions between, for 
example, RW, which ranges continuously from 0 to 20, and age, which ranges from 14 to 
105 in integer increments.  Scaling the data would make the magnitudes of the resulting 
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estimates of the regression coefficients uniform, and therefore, easier to compare.    
All regressors were scaled using unit length scaling [Montgomery 2001]: 







= , i = 1, 2,…, n,   j = 1, 2,…, k   (3-12) 







2)(     (3-13) 






2)( = 1.       
 
3.7.2 Coding of the Qualitative IP Regressor 
Coding for the 20 levels of the IP regressor can either be arbitrary or logical.  
However, it was shown that LOS does vary with IP (Figure 3.5).  As a result, it was 
believed a ranking scheme would be a slightly improved approach compared to a 
completely arbitrary one.  Therefore, the IPs are ranked (using unit length scaling) 
ascendingly according to the average percent difference between expected LOS 
(GMLOS) and actual LOS, as found in Figure 3.5 (AUTO, SELF-PAY,…, MEDICAID, 
NON-CONTRACTED COMMERCIAL). 
 
3.7.3 Data Binning 
 
 To calculate the weight estimates, the data was grouped into equally sized bins.  
Rather than use a complete arbitrary number of bins, n  was used, which is often the 
value used in grouping data for statistical methods, such as histogram graphs.  For this 
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model, this value is ~85 ( 7319 ).  This turns out to be a useful benchmark because 
many of the predictors have approximately this many distinct values.  For example, age 
has 92 values (14-105).  Some predictors (IP, gender) do not have this many levels, so the 
number of bins for those are simply the total number of levels.  RW, with 323 unique 
values, was grouped into 81 bins, with each bin having approximately four values of RW.  
Table 3.1 shows the number of bins for each predictor: 
Table 3.1 Number of Bins for each Predictor 
Predictor Unique values 
No of 
bins 
RW 323 81 
GMLOS 72 72 
AMLOS 96 96 
IP 20 20 
Age 92 92 
Gender 2 2 
 
For example, male patients with GMLOS=6.7, IP=13, and Age=56, will all have the 
same weight estimate, which will be calculated using that particular group of patients.  If 
the corresponding LOS variance estimate from this group is 25 days and the total number 
of patients is 10, then the corresponding weight estimates for WLS 1 and WLS 2 will be 
0.04 (1/25) and 10/7319, respectively. 
 
3.7.4 Multicollinearity Effects 
 
 It is highly suspected that the DRG regressors, particularly GMLOS and AMLOS, 
are highly linearly dependent and therefore, may be highly correlated with one another.  
Since )()ˆ( 2 XXVar Tσβ =  (for OLS), highly linear dependent columns of X will result 
in very large variances in the estimates of the model parameters.   
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Table 3.2 below shows that the DRG regressors are indeed highly correlated with one 
another (magnitude of coefficients > ~0.9): 
Table 3.2 Correlation Matrix ( XXT ) 
  RW GMLOS AMLOS Age Gender IP 
RW 1 0.906 0.904 -0.072 0.073 -0.047 
GMLOS   1 0.995 -0.018 0.035 0.008 
AMLOS     1 -0.011 0.039 0.014 
Age       1 -0.103 0.497 
Gender         1 -0.080 
IP Sym.         1 
 
However, these high values do not necessarily guarantee poorly estimated model 
parameters when using both of the corresponding regressors in the same model. Variance 
inflation factors (VIFs) are typically used to determine this.  VIFs are simply the diagonal 
elements of 1)( −XXT , or 1-1 )( −XVXT  and 1-1 )( −XWXT  for WLS, accordingly.  
Montgomery [18] states that if any of these exceed 5, the model parameters are poorly 
estimated due to multicollinearity.  As seen in Table 3.3, all three DRG regressors exceed 
this limit (RW = 5.788, GMLOS = 108.455, AMLOS = 106.354).   
   Table 3.3 Variance Inflation Factors 1)( −XXT  
  RW GMLOS AMLOS Age Gender IP 
RW 5.788 -3.795 -1.448 0.214 -0.197 0.203 
GMLOS   108.455 -104.528 0.459 0.658 0.223 
AMLOS     106.354 -0.630 -0.516 -0.432 
Age       1.347 0.080 -0.648 
Gender         1.022 0.035 
IP Sym.         1.339 
 
These high values indicate that any model with multiple DRG regressors will indeed have 




3.8 Model Ranking and Statistics of Performance 
 
 An approach has now been established to develop and study a regression model(s) 
based on this empirical patient data.  The ideal model(s) should be fairly simple, easy to 
implement, and require low maintenance.  While the main objectives are overall 
performance and simplicity, extensive comparisons of the OLS and WLS models will 
also be analyzed.   
To rank each potential model, a commonly used statistic, called Mallow’s Cp, will 
be used.  Mallow’s Cp is a very good statistic to use when comparing models with 
different values of p.  This statistic is a function of the residual sum of squares (SSRes) for 
the full regression model and that for the reduced model, which will be a model 
containing a combination of, but not all, the regressors. The equation for Cp is: 







                                      (3-14) 
where SSRes (p)is the error sum of squares for the reduced model with p terms, 2σ̂  is 
assumed to be an unbiased estimate of MSE (Mean Square Error = SSRes/(n-p)) for the 
full model and p = k + 1, where k is the number of regressors in the model.  Under the 
correct model, Cp is approximately equal to p and otherwise is typically greater than p, 
reflecting bias in the parameter estimates in the regression equation.  (A value less than p 
indicates the model is over-fitted.)  Thus, it is desirable to select a model in which the 









 The results of the regression analyses and model comparisons follow.  Section 4.2 
outlines summary statistics for all possible regressions followed by further analysis of the 
best-fit models (Section 4.3).  Final model analysis is performed in Section 4.4.  The 
chapter concludes with a comparison of the original simulation and proposed regression 
models to the original data (Section 4.5) before sensitivity analysis of the regression 
coefficients is performed in Section 4.6. 
 
 
4.2 Initial Regression Analysis 
 
The initial objective was to determine the significant regressors by studying all 
possible regressions.  However, the standard approach to performing this was modified 
somewhat.  Because of the multicollinearity effects mentioned in Chapter 3, no more than 
one DRG regressor will be present in any of the studied models.  Moreover, because it is 
assumed a DRG regressor must be present to accurately predict LOS, all models will 
contain one.  Because there are 3 DRG regressors (RW, GMLOS, AMLOS), 4 methods 
(OLS, WLS 1, WLS 2, WLS 3), and up to K = 3 additional regressors, this consisted of 
96 (3·4·2K) total regression models with the eight possible baseline regression models 





Table 4.1 All Possible Regressions 
DRG-regressor,  
DRG-regressor, IP  
DRG-regressor, Age 
DRG-regressor, Gender 
DRG-regressor, IP, Age  
DRG-regressor, IP, Gender 
DRG-regressor, Age, Gender  
DRG-regressor, IP, Age, Gender 
 
With so many models to be evaluated, a systematic approach to analyzing the various 
models was developed.  Since Mallow’s Cp statistic is based on the number of regressors 
in the model, or k, the idea was to analyze each group of models based on increasing 
values of k. 
Table 4.2 below shows the top 2-regressor models based on Mallow’s Cp statistic.    
Table 4.2 Top 2-Regressor Models 
Rank Regressors Method Mallow's Cp
1 AMLOS, IP WLS 2 7.7 
2 AMLOS, IP WLS 3 9.6 
3 GMLOS, IP OLS 9.7 
4 AMLOS, IP OLS 9.9 
5 AMLOS, IP WLS 2 13.5 
6 GMLOS, IP WLS 3 13.7 
7 GMLOS, IP WLS 1 16.4 
8 RW IP OLS 19.8 
9 RW IP WLS 1 25.7 
10 RW IP WLS 3 30.1 
  
The best method overall (Mallow’s Cp = 7.7) is the AMLOS, IP model using the WLS 2 
method.  Another AMLOS, IP model using the WLS 3 methods is the second (Cp = 9.6) 
best model.  As indicated in the table, AMLOS is the most significant DRG regressor, 
appearing in 4 of the top 5 models.  GMLOS and RW  are the second and third best DRG 
regressors, respectively.  IP is the most significant non-DRG regressor, while the effects 
of age and gender are effectively negligible.  The WLS methods, particularly WLS 2, 
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typically outperform OLS, with WLS 1 and WLS 3 performing comparatively to one 
another.   
Results of the analysis using 3-regressor models are shown in Table 4.3 below.   
Table 4.3 Top 3-regressor models 
 Rank Regressors Method
Mallow's 
Cp 
1 AMLOS, IP, Age WLS 2 3.7 
2 AMLOS, IP, Age WLS 3 4.0 
3 AMLOS, IP, Age OLS 4.1 
4 GMLOS, IP, Age OLS 4.9 
5 GMLOS, IP, Age WLS 3 6.6 
6 GMLOS, IP, Age WLS 2 6.7 
7 RW, IP, Age OLS 7.5 
8 RW, IP, Age WLS 2 8.1 
9 RW, IP, Age WLS 3 8.2 
10 AMLOS, IP, Gender WLS 2 8.7 
 
AMLOS and IP, when combined with age, continue to perform as well as they do in the 
2-regressor models, with the top 3 models consisting of all three.  IP continues to be the 
most significant non-DRG regressor, appearing in the top 9 models, while gender appears 
only once.  WLS 2 remains the best method, with WLS 1 and WLS 3 performing about 
the same. 
 Since MSres from the full regression (4-regressor) model is being used for 2σ̂ , the 
Mallow’s statistic for it will always be p, or k + 1 = 5.  However, the top four 3-regressor 
models are an improvement over this.  This indicates that gender adds no significance to 
the model, and therefore the 3-regressor models are superior to the full regression ones. 
 This analysis shows that the best 2 and 3 regressor models are AMLOS, IP and 
AMLOS, IP, Age, respectively, using the observed frequency approach (WLS 2).  Their 
corresponding ANOVA tables are found in Tables 4.4 and 4.5 below. 
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Regression 186690 2 93344.8 6141.09 0 
Residual 111203 7316 15.2     
Total 297893 7318      
 






Regression 182545 3 60848.5 4007.17 0 
Residual 111078 7315 15.2     
Total 293623 7318      
 
Since the p-values from each of the corresponding F tests are very small, it is concluded 
that LOS is related to AMLOS, IP, and/or Age.  Because it is not known exactly which of 
them is/are significant, further tests of model adequacy are required. 
 
4.3 Tests on Individual Regression Coefficients 
 Adding a variable to any regression model increases the variance of the fitted 
value ŷ  so care must be used to include only those that of real value in explaining the 
response.  Furthermore, adding an insignificant regressor may increase the residual mean 
square, possibly decreasing the model’s utility. 
 The hypothesis for testing the significance of the individual regression coefficient  
 
jβ  is: 
 















If 0:0 =jH β is not rejected, this indicates regressor xj can be removed from the model.  











=      (4-1) 
where Cjj is the diagonal element of 1)( −XXT corresponding to jβ̂ .  Note that this will be 
different from the X matrix studied earlier in Chapter 3 as X now only contains the two 
or three regressors currently under study as opposed to the original six.  The null 
hypothesis 0:0 =jH β is rejected if 1,2/0 || −−> kntt α .  This is actually a partial test because 
coefficient jβ̂  depends on all other regressor variables xi (i ≠ j) that are in the model.  In 
more general terms, this is a test of the contribution of xj given other variables are in the 
model.  As seen in Table 4.6 below, all coefficients for both models are statistically 
significant (α = 0.05). 
Table 4.6 Hypothesis Testing on the Individual Regression Coefficients 
     Model         Regressor      jβ̂           
2σ̂           jjC            0t        1,025.0 −−knt        Result 
AMLOS 203.55 15.2278 1.001 52.14 1.96  Reject H0 2 regressor IP 41.63 15.2278 1.001 10.66 1.96  Reject H0 
        
AMLOS 203.82 15.2138 1.001 52.23 1.96  Reject H0 
IP 30.73 15.2138 1.001 7.87 1.96  Reject H0 3 regressor 
Age 10.39 15.2138 1.001 2.66 1.96  Reject H0 
 
To determine the contribution of regressor xj, given that other regressors xi (i ≠ j) are 
included in the model, the extra-sum-of-squares method is generally used.  This can also 
be used to investigate the contribution of a subset of regressors.  For example, to 
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=     (4-2)  
where )()()|( 112 ββββ RRR SSSSSS −= , and )(βRSS and )( 1βRSS are the regression 
sum of squares forβ  and 1β , respectively.  If pnrFF −> ,,0 α , 0H is rejected, and it is 
concluded at least one of the parameters of 2β  is not zero.  In other words, at least one of 
these regressors contributes significantly to the model.  Table 4.7 below shows the results 
of the extra-sum-of-squares method:  
Table 4.7 Hypothesis Testing Using the Extra-Sum-of-Squares Method 
    Original Model   )( 1βRSS        2β           )(βRSS       0F      7315,1,05.0F       Result 
       
As seen in the table, both IP and age add statistically significance to the model.  
However, based on the F-statistic, IP is much more significant than age. 
 
 
4.4 Model Analysis 
 
 The two proposed models, AMLOS, IP, Age and AMLOS, IP, are defined by the 
following coefficients, respectively:  
 

































β                              
 
AMLOS 41566 IP 43297 113.67 3.84 Reject H0 
AMLOS, IP 43297 Age 43415 7.76 3.84 Reject H0
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The mathematical formulations for each respective model are then:  
          AgeIPAMLOS xxxy 006.0081.0951.068.1 +++−=   (4-3)  
                IPAMLOS xxy 092.0956.045.1 ++−=    (4-4) 
Table 4.8 shows a few of these models’ responses using observations from the original 
patient data.   
Table 4.8 Examples of Model Responses Using Original Patient Data  









4.6 MEDICARE 19 83 4.732 4.696 4.263
4.6 SELF PAY 2 58 3.205 3.132 3.630
13.0 ANTHEM TRADITIONAL 9 64 11.796 11.806 12.915
 
These results show the models will generally give a more accurate expected LOS than 
strictly using AMLOS.  The table also shows the models produce very similar outputs.  
This confirms the results of the extra-sum-of-squares method that showed age adds very 
little significance to the model.  
 
4.5 Model Comparison 
 
Each of the two proposed regression models was compared to the original 
simulation model provided to GSH. The only significant difference between the two 
models is that the GSH model is based on the most recent 18 months of patient data 
(January 2004 to June 2005), while the regression models consist of all 42 months of 
available data.  However, there was no significant change in hospital policy during this 
time that would have affected the flow and type of incoming patients.  Therefore, the 
patient distributions, and thus the resulting models, are assumed to be effectively similar.   
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 All three models were simulated using ARENATM software.  The statistics of 
primary interest are total and mean patient level and LOS, and to a lesser extent, max 
number of patients and min/max LOS.  The models were simulated in replicates of 42 
months, which is the total time range of the original patient data and is also long enough 
to give an accurate steady-state representation of the model.  Initially, 10 replicates were 
run to obtain sample variances which were then used to determine the eventual number of 
required replicates using the confidence interval half-width:  
           
R
StH R 1,2/ −= α     (4-5) 
Using a predetermined error criterion (ε), the objective is then to determine the minimum 
R which satisfies: 
202/ )(
ε
α SzR ≥      (4-6)  
For α = 0.05, ε1 = 0.15 patients for average patient level, and ε2 = 0.01 days for average 
LOS, 59 replications is the required minimum that satisfies all error criterion.  Table 4.9 
compares statistics from the simulation and regression models to the original data.   
Table 4.9 Comparison of Original Data to Simulation and Regression Models 




















Data 7319 ---- 24.98 ---- 42.5 ---- 4.443 ---- 0.002 94.549 
Simulation 
Model 7211.1 1.50% 23.838 4.79% 42.7 -0.47% 4.425 0.41% 0.095 72.103 
AMLOS,IP    
Regression 
Model 





7292.6 0.36% 25.099 -0.47% 45.5 -6.59% 4.517 -1.49% 0.562 48.925 
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All three models are comparable and represent the original data well, with percent 
differences for most statistics on the order of 1-3%. 
 
 
4.6 Sensitivity Analysis 
 
 To test the sensitivity of the model coefficients, confidence intervals were 
calculated for each of them.  This was accomplished by taking a random sample (without 
replacement) of half the total patients (3660 out of 7319) and in turn deriving a new 
model with this “new” pool of data.  Since it is assumed these coefficients are normally 
distributed, the following formula was used to calculate the CIs: 




1,2/ −± α     (4-7) 
where S2 is the sample variance and R is the number of replicates.  Using R = 100, and        
α = 0.05, the CIs are as shown below in Table 4.10:  
Table 4.10 Confidence Intervals of the Model Coefficients 
  AMLOS, Age, IP  AMLOS,IP 
    Y bar +/- Percent Diff  Y bar +/- 
Percent 
Diff 
β0    -1.652 0.109 6.60%  -1.434 0.076 5.30% 
β1   0.954 0.038 3.98%  0.957 0.043 4.49% 
β2   0.086 0.011 12.79%  0.094 0.009 9.57% 
β3   0.007 0.001 14.29%  ------- ------- ------- 
 
The percentage difference values represent half of the confidence interval and indicate 
how much the model coefficient is expected to vary in each direction.  As expected, the 
variability of the coefficient estimates is generally less for the 2-regressor model 
compared to the 3-regressor values.  To study the potential effects of this variability, both 
lower and upper bound estimates were simulated to see if any of the major simulation 
 46
statistics (average LOS and patient level) from Table 4.9 vary significantly.  While the 
overall patient levels did not change (the patient arrival distribution remains the same), 
Table 4.11 below shows how average LOS varied widely from 3.976-5.187 days 
compared to the narrow 4.517-4.543 day range (Table 4.9) of the original models. 
Table 4.11 Comparison of Confidence Interval Bounds on Original Regression Models 
 AMLOS, Age, IP Model AMLOS,IP Model 













β0 = -1.761 β0 = -1.510 
β1 = 0.916 β1 = 0.914 







   









β0 = -1.680 β0 = -1.450 
β1 = 0.951 β1 = 0.956 



















β0 = -1.543 β0 = -1.358 
β1 = 0.992 β1 = 1.000 







   





β3 = 0.008 




The level of patients in the upper bound once reached the maximum resource level in 
ARENA.  This causes the software to terminate prematurely and thus prevented the 
determination of a true maximum at the upper bound.  Regardless, this value is 
excessively larger than the top mark (62) of the original regression models.  Clearly these 
results illustrate two things.  Not only are the model coefficients very sensitive to change, 
but also the original model coefficients developed earlier appear to be estimated 
accurately, as shown by the data from the simulation runs in Table 4.9. 
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 The preceding research was performed to determine what, if any, relationship 
exists between general patient indicators and LOS in a neurology unit at a local hospital.  
A wide variety of analysis techniques were used to study, develop, and test regression 
models that will predict actual LOS more accurately than the hospital’s current system. 
 The process involved analyzing 6 various patient predictors, three related to the 
patient’s diagnosis (RW, AMLOS, and GMLOS) which are designated as DRG 
regressors.  The remaining three non-DRG regressors correspond directly to the patient 
(age, gender, and IP).  The data consists of 7319 patients treated in-residence at Good 
Samaritan Hospital in Dayton, OH, from January 2002 to June 2005. 
 Regression analysis involved comparing two different approaches: ordinary 
(OLS) and weighted least squares (WLS).  OLS was employed for its ease of 
implementation and as a baseline for comparing the three subsequent models.  WLS was 
used as a result of extensive analysis showing increasing variability in LOS as the DRG 
regressors increased.  Three various WLS methods were applied. 
Developing these models involved studying all possible models using all available 
regressors and using Mallow’s Cp statistic to rank them.  Normally, minimizing Mallow’s 
Cp statistic over all possible regression models will determine the best subset model.  
However, it was established early in the research process of the desire to develop a 
relatively simple, maintainable model.  Serious consideration was therefore given to a 
minimal-regressor model with a comparatively low Mallow’s Cp value. 
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  This analysis involved not only determining the top performing models, but more 
importantly, feasible ones.  Analysis determined that all three DRG regressors are highly 
linearly dependent and, consequently, highly collinear.  This typically translates into the 
model coefficients being poorly estimated, which was eventually demonstrated using 
Variance Inflation Factors.  It was ultimately concluded the final models must be limited 
to having a single DRG-regressor.  
 With this restriction in place and also presuming this particular DRG regressor 
would be the model’s most significant, choosing the most significant regressor is critical.  
Throughout the entire analysis, AMLOS consistently outperformed the two remaining 
DRG regressors (RW and GMLOS).  This is consistent with the policies of most health-
care facilities as AMLOS is typically used to predict LOS, while RW and GMLOS 
(indirectly) are used for calculating treatment costs.   
For the non-DRG regressors, IP was the most significant, appearing in virtually 
all of the top candidate models.  In one of the final models, LOS varies over 1.75 days 
when using two particular IPs.  However, since there is very little information known 
about each IP’s policies due to privacy issues, it can only be concluded that there is 
indeed a relationship, but any possible account or explanation as to why there is cannot 
be offered at this time.  Any attempt to do so at this point would be pure speculation. 
The two remaining non-DRG regressors, age and gender, were less significant, 
although age was eventually used in one of the models.  A possible reason for this is that 
many DRGs are only applicable to certain age groups, which means age has already been 
accounted for in many diagnoses.  The insignificance of gender, on the other hand, may 
easily be explained by the nervous system, unlike other systems of the human body, 
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being effectively the same for each gender, and therefore will tend to have similar 
diagnoses, treatments, and recovery times.  
The WLS methods were very effective, with many of the associated WLS models 
often outperforming OLS.  The drawback to WLS is that these models generally require 
more maintenance and upgrades than OLS.  However, WLS provides the user with a 
robust and powerful, yet simple approach to developing a regression model with 
nonconstant error variance that OLS cannot offer.  Furthermore, as more patient data 
becomes available, the WLS models will continue to be improved considerably. 
Each of the WLS approaches adds a particular element to regression analysis.  
WLS 1 (modeled variance) can be used in cases where little information about the total 
variance is known.  If enough points are known or can be determined by some method, an 
effective variance model can be developed to account for these unknown variances.  
WLS 2 (probability model), on the other hand, is a very effective, albeit less theoretical, 
approach to use when there is little or insufficient information known about the variance 
by simply “weighting” each observation based on its frequency of occurring.  WLS 3 
(isotonic) is a more innovative approach to modeling error variance, where a step 
function of the variance is developed by minimizing a convex function of the original 
data.  Its one drawback is that it must be thoroughly shown that the error variance is 
either nonincreasing (antitonic) or nondecreasing (isotonic).  
Because of its simplicity and ease of maintainability, the recommended model to 
implement is WLS 2.  As more patient data becomes available, the various weights can 
easily be adjusted to continuously update and improve the model.  Because WLS 1 and 
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WLS 3 consist of variance models, updating them is much more involved as the entire 
model has to be redeveloped to derive the new variance weights. 
 The final regression models are relatively simple, highly effective and have been 
extensively analyzed and tested.  Statistical data from their simulation runs was compared 
to both that of the original patient data and a simulation model developed from the raw 
patient data.  Results are quite favorable, with most statistics, such as average LOS and 
patient level, within 1-3% of one another.  Furthermore, these models are easily 
maintainable and updated as more patient and IP data becomes available. 
 The neurology department at Good Samaritan Hospital can now use these models 
to more effectively predict LOS for an incoming patient.  Inputting the patient’s AMLOS, 
age, and IP into the regression model generates an expected LOS that is much more 
accurate than their current guidelines for predicting LOS.  Furthermore, the respective 
simulation models offer a powerful tool for analyzing various what-if scenarios:   
• How does the system react to the anticipated increase in neurological patients?   
• What is the optimal number of beds that ensures minimal occurrence of patient 
overflow? 
• How is average LOS and average patient level impacted by small adjustments to 
the model?   
This research also offers GSH a basis to possibly investigate the disparities in 
LOS using two different IPs.  Certain IPs may have policies that possibly induce a shorter 
or longer LOS.  If so, it may be possible to alter or revise these procedures.  
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5.2 Future Research 
 
Because this patient data is used primarily for billing purposes, the information it 
offers is rather limited.  Ideally, more descriptive information of the patient would be 
desired, such as his or her past medical history and lifestyle (history of tobacco use, 
recent obesity problems, etc).  Furthermore, an admitted patient may have several 
additional symptoms that may or may not impact LOS.  However, policy states the 
patient can only be charged for one, and only one, diagnosis.   
Therefore, the finance office only tracks the one diagnosis code corresponding to 
the billing process.  Nevertheless, this will usually be the one reflecting the most 
substantial and costliest treatment(s) the patient receives, and therefore will generally 
impact LOS more significantly than the others.  However, if the patient has several 
additional diagnosis codes, it could significantly impact LOS. 
Also, since there has been a significant relationship established between patient IP 
and LOS, more information about each of the individuals IPs is desired.  As mentioned in 
Chapter 3, although each of the IPs is charged the actual amount it pays varies.  If certain 
details about these various payment methods were known, it may better explain the 














List of Acronyms 
 
ADL Activity of Daily Living  
AMLOS Arithmetic Mean LOS 
ANOVA Analysis-of-Variance 
CI Confidence Interval 
CMS Centers for Medicare and Medicaid Services 
DRG Diagnostic Related Group 
GMLOS Geometric Mean LOS 
GSH Good Samaritan Hospital (Dayton, OH) 
HMO Health Maintenance Organization 
IP Insurance Provider 
LOS Length-Of-Stay 
MATLAB Matrix Laboratory 
MWD Minimum Walking Distance 
PIE Person-In-Environment 
PPS Prospective Payment System  
PRESS Prediction Error Sum of Squares 
QL Quality of Life 
RW Relative Weight 
SAS Statistical Analysis System 
SPSS Statistical Package for the Social Sciences 
SSR Regression Sum of Squares 
SSRes Residual Sum of Squares 
SST Total Sum of Squares 
VIF Variance Inflation Factor 














The following are the derivations for the Regression Sum of Squares (SSR) and the 




































































































The data used in this research consists of the following Insurance Providers: 
 
Insurance Provider # of Patients 
AETNA 64 
ANTHEM MANAGED 545 
ANTHEM TRADITIONAL 51 
ASA 208 
AUTO 63 
BWC REHAB 67 
CIGNA 38 
CONTRACTED COMMERCIAL 182 
HUMANA 36 
MEDICAID 560 
MEDICAID HMO 63 
MEDICARE 3731 
MEDICARE HMO 412 
MMO 112 
NONCONTRACTED COMMERCIAL 39 
OTHER GOVERNMENTAL 13 
PHCS 66 
SELF PAY 393 
UHC MANAGED 521 
UHC TRADITIONAL 155 


















The following is the MATLAB code used in this research: 
 
% This function runs all possible regression models 
function [x] = RunAllModels() 
 
% Read in data matrix 
[datain] = textread('AMLOS_ulsx_rawy.txt');    
DataMatrix = datain; 
 
% Set number of bins 
r1 = 85; 
r2 = 97; 
r3 = 95; 
r4 = 92; 
r5 = 2; 
r6 = 20; 
 
% Run all 32 Regression Models                                   
% AMLOS 
Stats(1,:)   = RunModel(1, DataMatrix, 1, r1);        
% AMLOS, RW                
Stats(2,:)   = RunModel(2, DataMatrix, 1, r1, 2, r2);          
% AMLOS, GMLOS 
Stats(3,:)   = RunModel(2, DataMatrix, 1, r1, 3, r3);    
% AMLOS, Age                        
Stats(4,:)   = RunModel(2, DataMatrix, 1, r1, 4, r4);                            
% AMLOS, Gender 
Stats(5,:)   = RunModel(2, DataMatrix, 1, r1, 5, r5);                            
% AMLOS, IP 
Stats(6,:)   = RunModel(2, DataMatrix, 1, r1, 6, r6);      
% AMLOS, RW, GMLOS                       
Stats(7,:)   = RunModel(3, DataMatrix, 1, r1, 2, r2, 3, r3);  
% AMLOS, RW, Age                
Stats(8,:)   = RunModel(3, DataMatrix, 1, r1, 2, r2, 4, r4);                  
% AMLOS, RW, Gender 
Stats(9,:)   = RunModel(3, DataMatrix, 1, r1, 2, r2, 5, r5);  
% AMLOS, RW, IP                 
Stats(10,:) = RunModel(3, DataMatrix, 1, r1, 2, r2, 6, r6);   
% AMLOS, GMLOS, Age               
Stats(11,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 4, r4);                  
% AMLOS, GMLOS, Gender 
Stats(12,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 5, r5);     
% AMLOS, GMLOS, IP              
Stats(13,:) = RunModel(3, DataMatrix, 1, r1, 3, r3, 6, r6);  
% AMLOS, Age, Gender                 
Stats(14,:) = RunModel(3, DataMatrix, 1, r1, 4, r4, 5, r5);    
% AMLOS, Age, IP               
Stats(15,:) = RunModel(3, DataMatrix, 1, r1, 4, r4, 6, r6);   
% AMLOS, Gender, IP                
Stats(16,:) = RunModel(3, DataMatrix, 1, r1, 5, r5, 6, r6);   
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% AMLOS, RW, GMLOS, Age                
Stats(17,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4);       
% AMLOS, RW, GMLOS, Gender  
Stats(18,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 5, r5);  
  
% AMLOS, RW, GMLOS, IP 
Stats(19,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 3, r3, 6, r6);  
% AMLOS, RW, Age, Gender       
Stats(20,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 4, r4, 5, r5);        
% AMLOS, RW, Age, IP 
Stats(21,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 4, r4, 6, r6);  
% AMLOS, RW, Gender, IP      
Stats(22,:) = RunModel(4, DataMatrix, 1, r1, 2, r2, 5, r5, 6, r6);        
% AMLOS, GMLOS, Age, Gender 
Stats(23,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 4, r4, 5, r5); 
% AMLOS, GMLOS, Age, IP       
Stats(24,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 4, r4, 6, r6);        
% AMLOS, GMLOS, Gender, IP 
Stats(25,:) = RunModel(4, DataMatrix, 1, r1, 3, r3, 5, r5, 6, r6);        
 % AMLOS, Age, Gender, IP 
Stats(26,:) = RunModel(4, DataMatrix, 1, r1, 4, r4, 5, r5, 6, r6);   
% AMLOS, RW, GMLOS, Age, Gender   
Stats(27,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 5, r5);  
 % AMLOS, RW, GMLOS, Age, IP       
Stats(28,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 6, r6);             
 % AMLOS, RW, GMLOS, Gender, IP       
Stats(29,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 3, r3, 5, r5, 6, r6);             
 % AMLOS, RW, Age, Gender, IP       
Stats(30,:) = RunModel(5, DataMatrix, 1, r1, 2, r2, 4, r4, 5, r5, 6, r6);             
 % AMLOS, GMLOS, Age, Gender, IP       
Stats(31,:) = RunModel(5, DataMatrix, 1, r1, 3, r3, 4, r4, 5, r5, 6, r6);             
 % AMLOS, RW, GMLOS, Age, Gender, IP       
Stats(32,:) = RunModel(6, DataMatrix, 1, r1, 2, r2, 3, r3, 4, r4, 5, r5, 6, r6);   
 
% Set n 
n = length(randMat);    
 
% Total number of regression models 
totalruns = 32; 
 
% Generate matrix of 32 p-values corresponding to each regression model 
p = [1 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 4 4 4 5 5 5 5 5 6]; 
  
% Set values for all 32 models 
for(i = 1:totalruns) 
      for(j = 1:4) 
   % R^2 value 
           R2(i,j) = Stats(i,1+6*(j-1));    
                                                      
% Adjusted R^2 value 
adjR2(i,j) = Stats(i,2+6*(j-1));                                                         
 
           % Mean Square Error 
MS(i,j) = Stats(i,4+6*(j-1));                                                         
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           % Sum of Squares Total 
SStot(i,j) = Stats(i,5+6*(j-1));     
 
% PRESS Statistic                                                     
           PRESS(i,j) = 1 - ((Stats(i,6+6*(j-1)))/(SStot(i,j)));                          
            
% Mallow's Cp statistic 
Mallows_Cp(i,j) = ((Stats(i,3+6*(j-1)))/Stats(totalruns,4+6*(j-1))) - n +  
       (2*(p(i)+1));     
end 




% This function generates a random list of patients 
function z = GenDataMatrix(In, size_of_matrix, width) 
   
% Set a temp list from 1 to n 
   List = zeros(size_of_matrix,width); 
   
   % Set j to size of list 
   j = length(In);   
   
   % For 1 to size of list 
   for(i = 1:size_of_matrix)  
   
      % Find a random element and move it to the list   
      index = ceil((j)*rand(1)); 
      List(i,:) = In(index,:); 
     
      % Fill in the newly opened slot 
      for(n = index:(length(In)-1)) 
         In(n,:) = In(n+1,:); 
      end; 
     
      % Update j 
      j = j - 1; 
   end 
   
   % Return list 




% This function generates the Model (Beta) coefficients, ANOVA table, and residual plots 
function z = RunModel(number_of_reg, InMatrix, x1, t1, x2, t2, x3, t3, x4, t4, x5, t5 ) 
 
% Set y column 
y = 7; 
 
% Generate X and Y Matrices 
X(:,1) = ones(length(InMatrix),1); 
X(:,2) = InMatrix(:,x1); 
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Y        = InMatrix(:,y); 
if(number_of_reg >= 2) 
    X(:,3) = InMatrix(:,x2); 
end 
if(number_of_reg >= 3) 




if(number_of_reg >= 4) 
    X(:,5) = InMatrix(:,x4); 
end 
if(number_of_reg >= 5) 
    X(:,6) = InMatrix(:,x5);  
end 
if(number_of_reg >= 6) 
    X(:,7) = InMatrix(:,x6);  
end 
 
% Calculate Variances and Weights and set V and W Vectors 
VarsAndWeights = GenerateVarsAndWeights(InMatrix, x1, t1, y); 
 V  = VarsAndWeights(:,1); 
W = VarsAndWeights(:,2); 
 
% Derive Variance Model for WLS 2 
G = GLMfit(X(:,2),V); 
Var = X(:,1:2)*G; 
 
% Set n 
n = length(VarsAndWeights); 
 
% Generate VV, WW, and VarVar (nxn) matrices from the V, W, And Var vectors 
VV = zeros(n,n); 
WW = zeros(n,n); 
VarVar = zeros(n,n); 
for(i = 1:n) 
      % Elements cannot be exactly zero 
      if(V(i,1) == 0) 
           VV(i,i) = 0.00000001; 
      else 
           VV(i,i) = V(i,1);   
      end    
      if(W(i,1) == 0) 
           WW(i,i) = 0.00000001; 
      else 
           WW(i,i) = 1/W(i,1);   
      end    
      if(Var(i,1) == 0) 
           VarVar(i,i) = 0.00000001; 
      else 
           VarVar(i,i) = Var(i,1); 





% Model 1: OLS Model --------------------------------------------     
 
% Calculate Beta coefficients 
OLS_Model = (inv(X'*X))*X'*Y 
 
% Calculate ANOVA Table 
ANOVA(1,1:6) = ANOVAstats(OLS_Model,X,eye(n),Y,n,number_of_reg,1); 
 
% Calculate standardized and studentized residuals 
sta1 = Stand_res(OLS_Model,X,Y,ANOVA(1,4),n); 
stu1 = Stud_res(OLS_Model,X,eye(n),Y,ANOVA(1,4),n,number_of_reg); 
 
% Calculate y_hats 
for(i = 1:n) 
      y_hat(i,1) = X(i,:)*OLS_Model; 
end 
 
% Plot residuals 
figure (1) 
subplot(1,2,1) 
scatter(y_hat(:,1), sta1),title('M1: OLS Model Residuals'), 
     xlabel('y_hat'), ylabel('Standardized residual'); 
subplot(1,2,2) 
scatter(y_hat(:,1), stu1),title('M1: OLS Model Residuals'), 
          xlabel('y_hat'),ylabel('Studentized residual'); 
 
% Model 2: Modeled Variance ----------------------------------- 
 
% Calculate Beta coefficients 
Var_Model = inv(X'*inv(VarVar)*X)*X'*inv(VarVar)*Y 
 
% Calculate ANOVA Table 
ANOVA(1,7:12) = ANOVAstats(Var_Model,X,VarVar,Y,n,number_of_reg,2); 
 
% Calculate standardized and studentized residuals 
sta2 = Stand_res(Var_Model,X,Y,ANOVA(1,10),n); 
stu2 = Stud_res(Var_Model,X,VarVar,Y,ANOVA(1,10),n,number_of_reg); 
 
% Calculate y_hats 
for(i = 1:n) 
      y_hat(i,1) = X(i,:)*Var_Model; 
end 
 
% Plot residuals 
figure (2) 
subplot(1,2,1) 
scatter(y_hat(:,1), sta2),title('M2: Variance Model Residuals'), 
     xlabel('y_hat'),ylabel('Standardized residual'); 
subplot(1,2,2) 
scatter(y_hat(:,1), stu2),title('M2: Variance Model Residuals'), 
              xlabel('y_hat'),ylabel('Studentized residual'); 
 
% Model 3: Probability Model ----------------------------------- 
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% Calculate Beta coefficients 
Prob_Model = inv(X'*inv(WW)*X)*X'*inv(WW)*Y 
 
% Calculate ANOVA Table 
ANOVA(1,13:18) = ANOVAstats(Prob_Model,X,WW,Y,n,number_of_reg,2); 
 
% Calculate standardized and studentized residuals 
sta3 = Stand_res(Prob_Model,X,Y,ANOVA(1,16),n); 
stu3 = Stud_res(Prob_Model,X,WW,Y,ANOVA(1,16),n,number_of_reg); 
     
% Calculate y_hats 
for(i = 1:n) 
      y_hat(i,1) = X(i,:)*Prob_Model; 
end 
 
% Plot residuals 
figure (3) 
subplot(1,2,1) 
scatter(y_hat(:,1), sta3),title('M3: Probability Model Residuals'), 
     xlabel('y_hat'),ylabel('Standardized residual'); 
subplot(1,2,2) 
scatter(y_hat(:,1), stu3),title('M3: Probability Model Residuals'), 
          xlabel('y_hat'),ylabel('Studentized residual'); 
 
% Model 4: Isotonic Variance ------------------------------------ 
 
% Calculate Isotonic vector 
Isot = pavaI(V(:,1)); 
 
% Generate Isotonic matrix 
Isot_matrix = zeros(n,n); 
for(i = 1:n) 
      % Elements cannot be exactly zero 
      if(Isot(i) == 0)    
           Isot_matrix(i,i) = 0.00000001; 
      else  
           Isot_matrix(i,i) = Isot(i);         
      end     
end 
 
% Calculate Beta coefficients 
Isot_Model = inv(X'*inv(Isot_matrix)*X)*X'*inv(Isot_matrix)*Y 
 
% Calculate ANOVA Table 
ANOVA(1,19:24) = ANOVAstats(Isot_Model,X,Isot_matrix,Y,n,number_of_reg,2); 
 
% Calculate standardized and studentized residuals 
sta4 = Stand_res(Isot_Model,X,Y,ANOVA(1,22),n); 
stu4 =  Stud_res(Isot_Model,X,Isot_matrix,Y,ANOVA(1,22),n,number_of_reg); 
     
% Calculate y_hats 
for(i = 1:n) 




% Plot residuals 
Figure (4) 
subplot(1,2,1) 
scatter(y_hat(:,1), sta4),title('M4: Isotonic Model Residuals'), 
     xlabel('y_hat'),ylabel('Standardized residual'); 
subplot(1,2,2) 
scatter(y_hat(:,1), stu4),title('M4: Isotonic Model Residuals'), 
          xlabel('y_hat'),ylabel('Studentized residual'); 
 
% Return ANOVA table 
z = ANOVA; 
 
return 
% This function generates the ANOVA table 
function z = ANOVAstats(Model,X,V,Y,n,k,mode) 
 
% Calculate y_hats 
for(i = 1:length(Y)) 
      Y_hat(i,1) = X(i,:)*Model; 
end 
 
% Calculate vector of y_bar’s 
sum = 0; 
for(i = 1:length(Y)) 
      sum = sum + Y(i,1); 
end 
average = sum/length(Y); 
for(i = 1:length(Y)) 
      Y_bar(i,1) = average; 
end 
 
% Calculate SSr and SS_res 
SSr = (Y_hat-Y_bar)T*inv(V)*(Y_hat-Y_bar) 
SS_res  = Y'*inv(V)*Y - Y'*inv(V)*X*inv(X'*inv(V)*X)*X'*inv(V)*Y; 
 
% Create ANOVA Table 
ANOVA = zeros(3,5); 
ANOVA(1,1) = SSr; 
ANOVA(2,1) = SS_res; 
ANOVA(3,1) = SSr + SS_res; 
ANOVA(1,2) = k+1; 
ANOVA(2,2) = n - (k+1); 
ANOVA(3,2) = n; 
ANOVA(1,3) = ANOVA(1,1)/ANOVA(1,2);                      % Mean Square Regression 
ANOVA(2,3) = ANOVA(2,1)/ANOVA(2,2);                      % Mean Square Residual 
ANOVA(1,4) = ANOVA(1,3)/ANOVA(2,3);                      % F statistic 
 
% Set output statistics 
Out(1,1) = SSr/(SSr + SS_res)                             % R^2 
Out(1,2) = 1-((n-1)/(n-k-1))*(1-Out(1,1));                % adj R-squared 
Out(1,3) = ANOVA(2,1);                                    % Sum of Squares residual 
Out(1,4) = ANOVA(2,3);                                    % Mean Square 
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Out(1,5) = ANOVA(3,1);                                    % Sum of Squares total 
Out(1,6) = 1 - (PRESS(Model,X,V,Y,n,k,mode))/Out(1,5);   % PRESS statistic 
 
 % Return statistics 




% This function computes the standardized residuals 
function z = Stand_res(Model,X,Y,MS_res,n) 
for(i = 1:n) 
          residuals(i) = (Y(i,1) - (X(i,:)*Model))/sqrt(MS_res); 
     end 




% This function computes the studentized residuals 
function z = Stud_res(Model,X,V,Y,MS_res,n,k) 
 
     % Calculate H and covariance matrices 
     H = X*inv(X'*inv(V)*X)*X'*inv(V);   
     cov = (eye(n)-H)*V*(eye(n)-H)T; 
     
     for(i = 1:n) 
          residuals(i) = (Y(i,1) - (X(i,:)*Model))/(sqrt(MS_res*cov(i,i))); 
     end 




% This function computes the PRESS statistic 
function z = PRESS(Model,X,V,Y,n,k,mode) 
 
     % Calculate H matrix 
     H = X*inv(X'*inv(V)*X)*X'*inv(V);   
     
     % OLS 
     if(mode == 1) 
          newH = H; 
     else % WLS 2 
          newH = (eye(n)-H)*V*(eye(n)-H)T; 
     end 
     
     % Calculate PRESS statistic 
     PRESS_stat = 0; 
     for(i = 1:n) 
          PRESS_stat = PRESS_stat + ((Y(i,1) - (X(i,:)*Model))/(1 - newH(i,i)))^2; 
     end 




% This function calculates the variance and probability weight matrices 
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function z = GenerateVarsAndWeights( In, x1, t1, y ) 
     
  % Generate Used vector 
     Used = zeros(length(In),1); 
     
     % Set lower bound 
     low = -1; 
     
     % For each bin 
     for(j = 1:t1) 
         
          % Set upper bound and reset counter 
          upp = -1 + (2*j/t1); 
          cntr = 0; 
         
         % Traverse entire x1 vector 
         for(k = 1:length(In)) 
             
              % If element falls within bounds and has not already been used 
               if((Used(k,1) == 0) && (In(k,x1) >= low) && (In(k,x1) <= upp)) 
                    
% Increment counter 
                   cntr = cntr + 1; 
                    
                   % Load y and patient values 
                   yVector(cntr,1) = In(k,y); 
                  patientVector(cntr,1) = k; 
                 
                   % Set element as being used 
                   Used(k,1) = 1;  
                  end 
              end 
         
          % For all applicable elements in this bin 
          for(k = 1:cntr) 
               % Set Variance and weight values 
               Out(patientVector(k,1),1) = var(yVector(1:cntr,1)); 
               Out(patientVector(k,1),2) = cntr; 
          end 
         
          % Reset y and patient vectors 
          for(k = 1:cntr) 
               yVector(k,1) = 0; 
               patientVector(k,1) = 0; 
          end 
     end 
     
 % Return matrix 
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